alexa
Reach Us +1 218 451 2974
Editor - Terho LehtimÃki | University of Tampere School of Medi | 22303
ISSN: 2472-128X

Journal of Clinical & Medical Genomics
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Relevant Topics

Terho LehtimÃki

Terho LehtimÃki
Terho Lehtimäki
Professor
Chief Physician of the Department of Clinical Chemistry,
University of Tampere School of Medicine
Finland

Biography

Terho Lehtimäki (T.L.), MD, PhD, eMBA is currently a professor (since 2002-) of Clinical Chemistry and Chief Physician of the Department of Clinical Chemistry, University of Tampere School of Medicine and Fimlab Laboratories (Ltd), Finland which is one of the largest clinical laboratory in Finland (800 workers, with 100 million eur revenue). His research interests are focused on cardiovascular disease risk factors, atherosclerosis biomarkers, vascular and cell biology and functional genetics and epigenetics of complex traits and diseases. He has extensive experience in genome-wide association studies and related bioinformatics, as well as other omics and high density SNP maps and deep sequencing in population-based samples. T.L have a total over 900 publications (782 in press, 7 rewievs, 20 other articles and 119 in revision/submitted/manuscript). T.L has actively participated in over 50 New England J Med, Science, Lancet, Nature, Nature Genetics papers over the last 5 years, and his work in collaboration with many international consortia has led to the discovery of over 1600 novel genetic variants of complex traits. T.L holds a patent on a novel diagnostic test to predict statin myopathy.

Research Interest

Cardiovascular disease risk factors, Atherosclerosis biomarkers, Vascular and cell biology and functional genetics and Epigenetics of complex traits and diseases.

Certificate

Certificate
Leave Your Message 24x7
Top